{
  "_originalData": {
    "identity": {
      "bacteriumName": "Burkholderia cepacia",
      "aliases": [
        "B. cepacia"
      ],
      "lastUpdated": "2025-04-24",
      "clsiCategory": "Burkholderia cepacia complex",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Rod",
        "respiration": "Aerobic",
        "notes": []
      },
      "strainDetails": [
        {
          "type": "Complex Member",
          "value": "B. cenocepacia",
          "notes": ""
        },
        {
          "type": "Complex Member",
          "value": "B. multivorans",
          "notes": ""
        }
      ],
      "biochemicalTests": "Gram-negative rod, oxidase variable (usually weak + or â€“), catalase +, motile, non-lactose fermenter, oxidizes glucose, lysine decarboxylase +, ONPG +."
    },
    "clinicalProfile": {
      "summary": "Burkholderia cepacia complex is a group of bacteria that are important pulmonary pathogens, particularly in hospitalized patients and individuals with cystic fibrosis. They are known for their intrinsic resistance to multiple antibiotics, which complicates treatment.",
      "pathophysiologyPearls": [
        "The B. cepacia complex includes numerous distinct species, making precise identification important for predicting susceptibility.",
        "Infection is a significant cause of morbidity and mortality in cystic fibrosis patients."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Cough",
        "Shortness of breath",
        "Increased sputum production"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Pneumonia",
          "description": "Hospital-acquired or ventilator-associated pneumonia."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Often associated with contaminated medical devices or solutions."
        },
        {
          "syndromeName": "Cystic Fibrosis Pulmonary Exacerbation",
          "description": "Acute worsening of respiratory symptoms in patients with CF."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Patients with cystic fibrosis",
        "Immunocompromised patients",
        "Patients on mechanical ventilation"
      ],
      "transmissionVectors": [
        "Contaminated medical equipment",
        "Person-to-person contact among CF patients"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Aminoglycosides",
          "notes": "Usually resistant."
        },
        {
          "drugOrClass": "Colistin",
          "notes": "Intrinsically resistant."
        },
        {
          "drugOrClass": "Polymyxin B",
          "notes": "Intrinsically resistant."
        }
      ],
      "majorMechanisms": [
        {
          "mechanismName": "Multiple",
          "mechanismType": "Various",
          "description": "Multiple mechanisms of antibiotic resistance are variably expressed, complicating recommendations for empiric therapy."
        }
      ],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Antimicrobial therapy should be selected based on in vitro susceptibility.",
        "Consider combination therapy with two active drugs for more severe pulmonary infection."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "General Infection",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": ""
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Variable",
                  "drugs": [
                    {
                      "drugName": "Trimethoprim-Sulfamethoxazole",
                      "dose": "8-10 mg/kg/day",
                      "route": "IV",
                      "frequency": "q6h or q8h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Variable",
                  "drugs": [
                    {
                      "drugName": "Levofloxacin",
                      "dose": "750 mg",
                      "route": "IV/PO",
                      "frequency": "q24h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Variable",
                  "drugs": [
                    {
                      "drugName": "Minocycline",
                      "dose": "200 mg loading dose, then 100 mg",
                      "route": "IV/PO",
                      "frequency": "q12h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Variable",
                  "drugs": [
                    {
                      "drugName": "Meropenem",
                      "dose": "2 gm",
                      "route": "IV",
                      "frequency": "q8h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Variable",
                  "drugs": [
                    {
                      "drugName": "Ceftazidime",
                      "dose": "2 gm",
                      "route": "IV",
                      "frequency": "q8h",
                      "comments": "See drug-specific pearls."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [],
      "methodologyNotes": [
        "Susceptibility is highly variable and differs from species to species."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [
        "Susceptibility highly variable and differs from species to species; antimicrobial therapy should be selected based on in vitro susceptibility.",
        "Consider combination therapy with two active drugs for more severe pulmonary infection."
      ],
      "drugSpecificPearls": [
        {
          "drugName": "Ceftazidime-avibactam",
          "pearl": "May have in vitro activity against multiple drug resistant strains, including those resistant to Ceftazidime. In patient with persistent B. cepacia complex bacteremia, Ceftazidime-avibactam therapy cleared the bacteremia."
        },
        {
          "drugName": "Imipenem-relebactam",
          "pearl": "Active in vitro against Ceftazidime-resistant strains."
        },
        {
          "drugName": "Meropenem-vaborbactam",
          "pearl": "May be active against meropenem-resistant strains."
        },
        {
          "drugName": "Cefiderocol",
          "pearl": "Active in vitro but clinical data supporting efficacy are lacking; may be a reasonable option, particularly for infections caused by highly drug-resistant strains."
        },
        {
          "drugName": "Delafloxacin",
          "pearl": "Active in vitro."
        },
        {
          "drugName": "Temocillin",
          "pearl": "Demonstrates potent inhibitory activity vs. MDR Burkholderia species including strains that produce AmpC and ESBLs."
        }
      ],
      "guidelineReferences": [
        {
          "source": "Syst Appl Microbiol",
          "citation": "34:87, 2011",
          "summaryOrNote": "Taxonomy of B. cepacia complex."
        },
        {
          "source": "Clin Microbiol Infect",
          "citation": "16:821, 2010",
          "summaryOrNote": "Clinical significance of B. cepacia complex."
        },
        {
          "source": "ACS Infect Dis",
          "citation": "2017;3:502",
          "summaryOrNote": "Ceftazidime-avibactam activity."
        },
        {
          "source": "Antimicrob Agents Chemother",
          "citation": "2018;62:e02213-17",
          "summaryOrNote": "Ceftazidime-avibactam clinical case."
        },
        {
          "source": "Antimicrob Agents Chemother",
          "citation": "2021 Oct 18;65(11):e0133221",
          "summaryOrNote": "Imipenem-relebactam activity."
        },
        {
          "source": "Antimicrob Agents Chemother",
          "citation": "2023; 67(12):e0034623",
          "summaryOrNote": "Meropenem-vaborbactam and Cefiderocol activity."
        },
        {
          "source": "Future Microbiol",
          "citation": "2023; Jan:18:117",
          "summaryOrNote": "Meropenem-vaborbactam and Delafloxacin activity."
        },
        {
          "source": "Antimicrob Agents Chemother",
          "citation": "2021; 65:e0217120",
          "summaryOrNote": "Cefiderocol activity."
        },
        {
          "source": "Antimicrob Agt Chemother",
          "citation": "2019; 63: e02315-18",
          "summaryOrNote": "Temocillin activity."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.261Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Burkholderia cepacia"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "B. cepacia"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2025-04-24"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Rod",
        "respiration": "Aerobic",
        "notes": []
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Burkholderia cepacia complex is a group of bacteria that are important pulmonary pathogens, particularly in hospitalized patients and individuals with cystic fibrosis. They are known for their intrinsic resistance to multiple antibiotics, which complicates treatment.",
      "pathophysiologyPearls": [
        "The B. cepacia complex includes numerous distinct species, making precise identification important for predicting susceptibility.",
        "Infection is a significant cause of morbidity and mortality in cystic fibrosis patients."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Cough",
        "Shortness of breath",
        "Increased sputum production"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Pneumonia",
          "description": "Hospital-acquired or ventilator-associated pneumonia."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Often associated with contaminated medical devices or solutions."
        },
        {
          "syndromeName": "Cystic Fibrosis Pulmonary Exacerbation",
          "description": "Acute worsening of respiratory symptoms in patients with CF."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Patients with cystic fibrosis",
        "Immunocompromised patients",
        "Patients on mechanical ventilation"
      ],
      "transmissionVectors": [
        "Contaminated medical equipment",
        "Person-to-person contact among CF patients"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Aminoglycosides",
          "notes": "Usually resistant."
        },
        {
          "drugOrClass": "Colistin",
          "notes": "Intrinsically resistant."
        },
        {
          "drugOrClass": "Polymyxin B",
          "notes": "Intrinsically resistant."
        }
      ],
      "majorMechanisms": [
        {
          "mechanismName": "Multiple",
          "mechanismType": "Various",
          "description": "Multiple mechanisms of antibiotic resistance are variably expressed, complicating recommendations for empiric therapy."
        }
      ],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "General Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": ""
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Trimethoprim-Sulfamethoxazole",
              "dose": "8-10 mg/kg/day",
              "route": "IV",
              "frequency": "q6h or q8h",
              "duration": "Variable",
              "comments": "",
              "originalText": "Trimethoprim-Sulfamethoxazole 8-10 mg/kg/day IV q6h or q8h"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "General Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": ""
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Levofloxacin",
              "dose": "750 mg",
              "route": "IV/PO",
              "frequency": "q24h",
              "duration": "Variable",
              "comments": "",
              "originalText": "Levofloxacin 750 mg IV/PO q24h"
            }
          ]
        },
        {
          "regimenId": "modern-0-2-0",
          "extractedFrom": "treatment.regimens[0].recommendations[2].steps[0]",
          "context": {
            "type": "directed",
            "condition": "General Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": ""
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Minocycline",
              "dose": "200 mg loading dose, then 100 mg",
              "route": "IV/PO",
              "frequency": "q12h",
              "duration": "Variable",
              "comments": "",
              "originalText": "Minocycline 200 mg loading dose, then 100 mg IV/PO q12h"
            }
          ]
        },
        {
          "regimenId": "modern-0-3-0",
          "extractedFrom": "treatment.regimens[0].recommendations[3].steps[0]",
          "context": {
            "type": "directed",
            "condition": "General Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": ""
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Meropenem",
              "dose": "2 gm",
              "route": "IV",
              "frequency": "q8h",
              "duration": "Variable",
              "comments": "",
              "originalText": "Meropenem 2 gm IV q8h"
            }
          ]
        },
        {
          "regimenId": "modern-0-4-0",
          "extractedFrom": "treatment.regimens[0].recommendations[4].steps[0]",
          "context": {
            "type": "directed",
            "condition": "General Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": ""
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Ceftazidime",
              "dose": "2 gm",
              "route": "IV",
              "frequency": "q8h",
              "duration": "Variable",
              "comments": "See drug-specific pearls.",
              "originalText": "Ceftazidime 2 gm IV q8h"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [],
      "methodologyNotes": [
        "Susceptibility is highly variable and differs from species to species."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}